The Legal Intelligencer | News
By Zack Needles | October 8, 2018
Thanks to two recent Pennsylvania Superior Court rulings upholding the "consent by registration" theory of jurisdiction, the first ovarian-cancer-related talc case in the Philadelphia Court of Common Pleas has been allowed to proceed.
The Legal Intelligencer | News
By Max Mitchell | September 19, 2018
U.S. District Judge Mitchell Goldberg of the Eastern District of Pennsylvania ruled Wednesday that a 2015 memorandum of understanding between United HealthCare Services and three drug companies was binding.
The Legal Intelligencer | News
By Lizzy McLellan | September 17, 2018
Montgomery McCracken's former chairman is among the group launching St. Louis-based Armstrong Teasdale's first East Coast office.
The Legal Intelligencer | Commentary
By Sid Steinberg | September 11, 2018
National origin discrimination claims typically involve allegations of discrimination based on an employee's non-American country of origin. Middlebrooks v. Teva Pharmaceuticals USA, Civ. A. No. 17-412 (E.D. Pa. Aug. 31, 2018) involved the atypical claim of alleged national origin discrimination based on anti-American bias.
The Legal Intelligencer | Commentary
By Steve Schain | August 31, 2018
With Corona brewer and Robert Mondavi wine producer Constellation Brands Inc. investing $3.88 billion in grower Canopy Growth Corp. and the Wall Street Journal estimating 2018 U.S. legal marijuana sales at $10.2 billion, the writing's on the wall: cannabis is big business and ripe for the plucking by the plaintiffs bar.
The Legal Intelligencer | News
By Max Mitchell | August 30, 2018
The verdict marked the second straight defense verdict out of Philadelphia for drugmakers Bayer and Janssen Pharmaceuticals, which saw similar wins in a string of cases tried last year in federal court.
The Legal Intelligencer | News
By Max Mitchell | August 29, 2018
In a rush to bring Xarelto to market, drugmakers Bayer and Janssen Pharmaceuticals skipped needed testing that would have provided the basis for a more accurate warning label, plaintiffs counsel in the latest trial over the blood thinner told a Philadelphia jury Wednesday.
The Legal Intelligencer | News
By P.J. D'Annunzio | August 28, 2018
Insys, the manufacturer of the fentanyl drug Subsys, used most commonly for cancer patients, encouraged doctors to prescribe the painkiller for uses other than those approved by the FDA, Aetna alleged.
The Legal Intelligencer | News
By Amanda Bronstad | August 15, 2018
Opioid manufacturers and one distributor say the complaint against them lacks specifics to back up deceptive trade practices and public nuisance claims. But the amicus briefs said none of that mattered because a state has a “unique role” in the opioid crisis.
The Legal Intelligencer | News
By Max Mitchell | August 13, 2018
The ruling allows Pfizer to proceed with its antitrust lawsuit against J&J on allegations that rebate programs J&J entered into with insurers and hospitals were designed to curb competition.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Seeking a compassionate and experienced estate administration attorney for growing boutique estate planning and elder law practice. Huge eq...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS